These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 31344346
1. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases. Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group. Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil for ocular inflammation. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178 [Abstract] [Full Text] [Related]
4. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE. Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209 [Abstract] [Full Text] [Related]
5. Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial. Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Arellanes-Garcia L, Coyne A, Porco TC, Shantha JG, FAST Research Group. Am J Ophthalmol; 2024 Nov; 267():100-111. PubMed ID: 38909740 [Abstract] [Full Text] [Related]
6. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Sobrin L, Christen W, Foster CS. Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998 [Abstract] [Full Text] [Related]
7. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease. Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F. J Ocul Pharmacol Ther; 2016 Aug; 32(1):55-61. PubMed ID: 26562247 [Abstract] [Full Text] [Related]
8. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR. Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273 [Abstract] [Full Text] [Related]
9. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial. Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group. JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307 [Abstract] [Full Text] [Related]
10. Mycophenolate mofetil therapy for inflammatory eye disease. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Ophthalmology; 2005 Aug 10; 112(8):1472-7. PubMed ID: 16061096 [Abstract] [Full Text] [Related]
11. Mycophenolate versus Methotrexate in Non-infectious Ocular Inflammatory Disease: A Systematic Review and Meta-Analysis. Karam M, Alsaif A, Al-Naseem A, Hayre A, Al Jabbouri A, Aldubaikhi A, Kahlar N, Al-Mutairi S. Ocul Immunol Inflamm; 2023 Apr 10; 31(3):613-620. PubMed ID: 35201968 [Abstract] [Full Text] [Related]
12. Mycophenolate mofetil for the treatment of scleritis. Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Ophthalmology; 2003 Sep 10; 110(9):1750-5. PubMed ID: 13129873 [Abstract] [Full Text] [Related]
13. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI. Ophthalmology; 2013 Feb 10; 120(2):379-86. PubMed ID: 23177360 [Abstract] [Full Text] [Related]
14. Cyclophosphamide for ocular inflammatory diseases. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Ophthalmology; 2010 Feb 10; 117(2):356-65. PubMed ID: 19969366 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis. Rodriguez EE, Sakata VM, Cavalcanti DC, Zaghetto JM, Olivalves E, Hirata CE, Yamamoto JH. Arq Bras Oftalmol; 2016 Feb 10; 79(6):369-372. PubMed ID: 28076562 [Abstract] [Full Text] [Related]
16. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. Acta Ophthalmol; 2012 Dec 10; 90(8):e603-8. PubMed ID: 22971163 [Abstract] [Full Text] [Related]
17. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review. Nosadini M, Mohammad SS, Toldo I, Sartori S, Dale RC. Eur J Paediatr Neurol; 2019 Jan 10; 23(1):7-18. PubMed ID: 30318435 [Abstract] [Full Text] [Related]
18. Cyclosporine for ocular inflammatory diseases. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Ophthalmology; 2010 Mar 10; 117(3):576-84. PubMed ID: 20031223 [Abstract] [Full Text] [Related]
19. Mycophenolate mofetil for the treatment of uveitis. Teoh SC, Hogan AC, Dick AD, Lee RW. Am J Ophthalmol; 2008 Nov 10; 146(5):752-60, 760.e1-3. PubMed ID: 18455143 [Abstract] [Full Text] [Related]
20. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C. Graefes Arch Clin Exp Ophthalmol; 2011 Aug 10; 249(8):1235-43. PubMed ID: 21720813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]